ALTIMMUNE, INC.

ALT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-46.4M $-11.1M $-3.4M $-10.0M $-11.7M $-4.9M $-3.8M $-34.8M
Depreciation & Amortization $303.9K $461.1K $1.0M
Depreciation $83.8K $63.1K $141.6K $150.0K $182.5K $303.9K $461.1K
Amortization
Stock-Based Compensation $1.4M $965.4K $613.0K $1.7M $1.4M $1.9M $2.6M $2.5M
Net Cash from Operating Activities $-20.2M $-6.4M $-3.2M $-8.5M $-7.2M $-2.3M $-7.8M $-14.9M
Investing Activities
Capital Expenditures $112.4K $125.0K $86.5K $92.3K $84.6K $71.4K $374.6K
Business Acquisitions
Net Cash from Investing Activities $13.7M $67.4K $1.7M $2.8M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $15.8M $3.7M $5.8M $21.5M
Net Change in Cash $9.4M $138.4M $-3.1M $8.2M $-2.2M $1.5M $-548.6K $9.1M
Free Cash Flow $-20.3M $-6.5M $-3.3M $-8.6M $-7.3M $-7.9M $-15.2M
← Newer Page 2 of 2 Older →